nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—mammary gland—breast cancer	0.0316	0.431	CbGeAlD
Gentamicin—LRP2—epithelium—breast cancer	0.0176	0.24	CbGeAlD
Gentamicin—LRP2—female reproductive system—breast cancer	0.0131	0.178	CbGeAlD
Gentamicin—LRP2—endocrine gland—breast cancer	0.0111	0.151	CbGeAlD
Gentamicin—LRP2—Metabolism—ABCG2—breast cancer	0.000448	0.00142	CbGpPWpGaD
Gentamicin—LRP2—Disease—FASN—breast cancer	0.000445	0.00142	CbGpPWpGaD
Gentamicin—LRP2—Disease—JAG1—breast cancer	0.000445	0.00142	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LPAR1—breast cancer	0.000445	0.00141	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TLE3—breast cancer	0.000445	0.00141	CbGpPWpGaD
Gentamicin—LRP2—Disease—PARP1—breast cancer	0.000443	0.00141	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HEY1—breast cancer	0.000441	0.0014	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HPGDS—breast cancer	0.000439	0.0014	CbGpPWpGaD
Gentamicin—LRP2—Disease—CALCA—breast cancer	0.000438	0.00139	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HBA1—breast cancer	0.000437	0.00139	CbGpPWpGaD
Gentamicin—LRP2—Disease—RPS6—breast cancer	0.000433	0.00138	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—DLL1—breast cancer	0.000432	0.00137	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGF4—breast cancer	0.000429	0.00136	CbGpPWpGaD
Gentamicin—LRP2—Disease—CXCR4—breast cancer	0.000428	0.00136	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ACHE—breast cancer	0.000426	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTT1—breast cancer	0.000426	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIST1H2BK—breast cancer	0.000424	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIST1H2BC—breast cancer	0.000424	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Disease—SLC2A1—breast cancer	0.000423	0.00134	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GRB7—breast cancer	0.00042	0.00134	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDE4D—breast cancer	0.00042	0.00134	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TAB2—breast cancer	0.000413	0.00131	CbGpPWpGaD
Gentamicin—LRP2—Disease—TCF7L2—breast cancer	0.000412	0.00131	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000411	0.00131	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CNR2—breast cancer	0.00041	0.0013	CbGpPWpGaD
Gentamicin—Dizziness—Goserelin—breast cancer	0.000405	0.000661	CcSEcCtD
Gentamicin—Hypotension—Fluorouracil—breast cancer	0.000405	0.000661	CcSEcCtD
Gentamicin—Leukopenia—Paclitaxel—breast cancer	0.000404	0.000661	CcSEcCtD
Gentamicin—Rash—Tamoxifen—breast cancer	0.000404	0.00066	CcSEcCtD
Gentamicin—Hypersensitivity—Vinorelbine—breast cancer	0.000404	0.00066	CcSEcCtD
Gentamicin—Dermatitis—Tamoxifen—breast cancer	0.000404	0.000659	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000403	0.00128	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP17A1—breast cancer	0.000403	0.00128	CbGpPWpGaD
Gentamicin—Headache—Tamoxifen—breast cancer	0.000401	0.000656	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000401	0.000655	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—DKK1—breast cancer	0.0004	0.00127	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS1—breast cancer	0.000399	0.00127	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ENO1—breast cancer	0.000399	0.00127	CbGpPWpGaD
Gentamicin—Vomiting—Melphalan—breast cancer	0.000399	0.000652	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000398	0.00126	CbGpPWpGaD
Gentamicin—LRP2—Disease—HSP90AA1—breast cancer	0.000398	0.00126	CbGpPWpGaD
Gentamicin—Tinnitus—Capecitabine—breast cancer	0.000397	0.000649	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—VEGFC—breast cancer	0.000397	0.00126	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000396	0.00126	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000396	0.00126	CbGpPWpGaD
Gentamicin—Rash—Melphalan—breast cancer	0.000396	0.000646	CcSEcCtD
Gentamicin—Paraesthesia—Gemcitabine—breast cancer	0.000395	0.000646	CcSEcCtD
Gentamicin—Dermatitis—Melphalan—breast cancer	0.000395	0.000646	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000394	0.000644	CcSEcCtD
Gentamicin—Decreased appetite—Mitoxantrone—breast cancer	0.000393	0.000642	CcSEcCtD
Gentamicin—Decreased appetite—Irinotecan—breast cancer	0.000393	0.000642	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000393	0.00125	CbGpPWpGaD
Gentamicin—Eosinophilia—Methotrexate—breast cancer	0.000392	0.000641	CcSEcCtD
Gentamicin—Nausea—Vinblastine—breast cancer	0.000392	0.00064	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP2D6—breast cancer	0.000392	0.00124	CbGpPWpGaD
Gentamicin—Convulsion—Paclitaxel—breast cancer	0.000391	0.000639	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—JAG2—breast cancer	0.000391	0.00124	CbGpPWpGaD
Gentamicin—Hypokalaemia—Epirubicin—breast cancer	0.00039	0.000638	CcSEcCtD
Gentamicin—Hypertension—Paclitaxel—breast cancer	0.00039	0.000637	CcSEcCtD
Gentamicin—Vomiting—Goserelin—breast cancer	0.000389	0.000636	CcSEcCtD
Gentamicin—Paraesthesia—Fluorouracil—breast cancer	0.000389	0.000635	CcSEcCtD
Gentamicin—Alopecia—Docetaxel—breast cancer	0.000389	0.000635	CcSEcCtD
Gentamicin—Pruritus—Vinorelbine—breast cancer	0.000388	0.000633	CcSEcCtD
Gentamicin—LRP2—Disease—PRL—breast cancer	0.000387	0.00123	CbGpPWpGaD
Gentamicin—Rash—Goserelin—breast cancer	0.000386	0.00063	CcSEcCtD
Gentamicin—Hypersensitivity—Thiotepa—breast cancer	0.000386	0.00063	CcSEcCtD
Gentamicin—Dermatitis—Goserelin—breast cancer	0.000385	0.00063	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—WNT1—breast cancer	0.000385	0.00122	CbGpPWpGaD
Gentamicin—Arthralgia—Paclitaxel—breast cancer	0.000385	0.000628	CcSEcCtD
Gentamicin—LRP2—Metabolism—NCOA2—breast cancer	0.000384	0.00122	CbGpPWpGaD
Gentamicin—Headache—Goserelin—breast cancer	0.000383	0.000626	CcSEcCtD
Gentamicin—Erythema—Docetaxel—breast cancer	0.000383	0.000625	CcSEcCtD
Gentamicin—Decreased appetite—Gemcitabine—breast cancer	0.000383	0.000625	CcSEcCtD
Gentamicin—LRP2—Disease—ADAM10—breast cancer	0.000381	0.00121	CbGpPWpGaD
Gentamicin—Nausea—Tamoxifen—breast cancer	0.000381	0.000622	CcSEcCtD
Gentamicin—Muscular weakness—Epirubicin—breast cancer	0.000378	0.000618	CcSEcCtD
Gentamicin—Decreased appetite—Fluorouracil—breast cancer	0.000376	0.000615	CcSEcCtD
Gentamicin—Alopecia—Capecitabine—breast cancer	0.000376	0.000615	CcSEcCtD
Gentamicin—LRP2—Metabolism—FASN—breast cancer	0.000373	0.00119	CbGpPWpGaD
Gentamicin—Nausea—Melphalan—breast cancer	0.000373	0.000609	CcSEcCtD
Gentamicin—Feeling abnormal—Mitoxantrone—breast cancer	0.000372	0.000609	CcSEcCtD
Gentamicin—Feeling abnormal—Irinotecan—breast cancer	0.000372	0.000609	CcSEcCtD
Gentamicin—Confusional state—Paclitaxel—breast cancer	0.000372	0.000607	CcSEcCtD
Gentamicin—LRP2—Metabolism—BCHE—breast cancer	0.000371	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGF10—breast cancer	0.000371	0.00118	CbGpPWpGaD
Gentamicin—Erythema—Capecitabine—breast cancer	0.000371	0.000606	CcSEcCtD
Gentamicin—Pruritus—Thiotepa—breast cancer	0.00037	0.000605	CcSEcCtD
Gentamicin—Anaphylactic shock—Paclitaxel—breast cancer	0.000369	0.000602	CcSEcCtD
Gentamicin—Eosinophilia—Epirubicin—breast cancer	0.000367	0.000599	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC5A5—breast cancer	0.000367	0.00117	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOTCH4—breast cancer	0.000365	0.00116	CbGpPWpGaD
Gentamicin—Nausea—Goserelin—breast cancer	0.000363	0.000594	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GZMB—breast cancer	0.000363	0.00115	CbGpPWpGaD
Gentamicin—Feeling abnormal—Gemcitabine—breast cancer	0.000363	0.000593	CcSEcCtD
Gentamicin—Dizziness—Vinorelbine—breast cancer	0.000362	0.000592	CcSEcCtD
Gentamicin—Hypokalaemia—Doxorubicin—breast cancer	0.000361	0.00059	CcSEcCtD
Gentamicin—Thrombocytopenia—Paclitaxel—breast cancer	0.000361	0.00059	CcSEcCtD
Gentamicin—Urticaria—Mitoxantrone—breast cancer	0.000359	0.000587	CcSEcCtD
Gentamicin—LRP2—Disease—PDGFA—breast cancer	0.000358	0.00114	CbGpPWpGaD
Gentamicin—Body temperature increased—Mitoxantrone—breast cancer	0.000357	0.000584	CcSEcCtD
Gentamicin—Body temperature increased—Irinotecan—breast cancer	0.000357	0.000584	CcSEcCtD
Gentamicin—Feeling abnormal—Fluorouracil—breast cancer	0.000357	0.000583	CcSEcCtD
Gentamicin—LRP2—Metabolism—NQO1—breast cancer	0.000354	0.00113	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SLC2A1—breast cancer	0.000354	0.00113	CbGpPWpGaD
Gentamicin—Anaemia—Docetaxel—breast cancer	0.000354	0.000578	CcSEcCtD
Gentamicin—LRP2—Disease—TGFBR2—breast cancer	0.000353	0.00112	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL2—breast cancer	0.000352	0.00112	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AGTR2—breast cancer	0.000352	0.00112	CbGpPWpGaD
Gentamicin—Muscular weakness—Doxorubicin—breast cancer	0.00035	0.000572	CcSEcCtD
Gentamicin—Vomiting—Vinorelbine—breast cancer	0.000348	0.000569	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PTHLH—breast cancer	0.000348	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—BMP2—breast cancer	0.000348	0.00111	CbGpPWpGaD
Gentamicin—Body temperature increased—Gemcitabine—breast cancer	0.000348	0.000569	CcSEcCtD
Gentamicin—LRP2—Disease—ITPR1—breast cancer	0.000347	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000347	0.0011	CbGpPWpGaD
Gentamicin—Dizziness—Thiotepa—breast cancer	0.000346	0.000565	CcSEcCtD
Gentamicin—Rash—Vinorelbine—breast cancer	0.000346	0.000565	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP3A4—breast cancer	0.000345	0.0011	CbGpPWpGaD
Gentamicin—Dermatitis—Vinorelbine—breast cancer	0.000345	0.000564	CcSEcCtD
Gentamicin—LRP2—Disease—ERBB4—breast cancer	0.000345	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT5A—breast cancer	0.000345	0.0011	CbGpPWpGaD
Gentamicin—Hypotension—Paclitaxel—breast cancer	0.000344	0.000563	CcSEcCtD
Gentamicin—Stomatitis—Methotrexate—breast cancer	0.000344	0.000562	CcSEcCtD
Gentamicin—Urticaria—Fluorouracil—breast cancer	0.000344	0.000562	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000344	0.00109	CbGpPWpGaD
Gentamicin—Headache—Vinorelbine—breast cancer	0.000343	0.000561	CcSEcCtD
Gentamicin—Leukopenia—Docetaxel—breast cancer	0.000343	0.00056	CcSEcCtD
Gentamicin—Anaemia—Capecitabine—breast cancer	0.000343	0.00056	CcSEcCtD
Gentamicin—Body temperature increased—Fluorouracil—breast cancer	0.000342	0.000559	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000341	0.00108	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP1B1—breast cancer	0.00034	0.00108	CbGpPWpGaD
Gentamicin—Eosinophilia—Doxorubicin—breast cancer	0.00034	0.000555	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—EDNRB—breast cancer	0.000337	0.00107	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000336	0.000549	CcSEcCtD
Gentamicin—Weight decreased—Epirubicin—breast cancer	0.000335	0.000548	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PGR—breast cancer	0.000334	0.00106	CbGpPWpGaD
Gentamicin—LRP2—Disease—SMAD4—breast cancer	0.000334	0.00106	CbGpPWpGaD
Gentamicin—Vertigo—Capecitabine—breast cancer	0.000333	0.000544	CcSEcCtD
Gentamicin—Hypersensitivity—Mitoxantrone—breast cancer	0.000333	0.000544	CcSEcCtD
Gentamicin—Hypersensitivity—Irinotecan—breast cancer	0.000333	0.000544	CcSEcCtD
Gentamicin—LRP2—Metabolism—HSP90AA1—breast cancer	0.000333	0.00106	CbGpPWpGaD
Gentamicin—Vomiting—Thiotepa—breast cancer	0.000333	0.000544	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—THBS1—breast cancer	0.000332	0.00106	CbGpPWpGaD
Gentamicin—Leukopenia—Capecitabine—breast cancer	0.000332	0.000542	CcSEcCtD
Gentamicin—Convulsion—Docetaxel—breast cancer	0.000332	0.000542	CcSEcCtD
Gentamicin—Paraesthesia—Paclitaxel—breast cancer	0.000331	0.000541	CcSEcCtD
Gentamicin—Hypertension—Docetaxel—breast cancer	0.000331	0.00054	CcSEcCtD
Gentamicin—Rash—Thiotepa—breast cancer	0.00033	0.000539	CcSEcCtD
Gentamicin—Dermatitis—Thiotepa—breast cancer	0.00033	0.000539	CcSEcCtD
Gentamicin—Agranulocytosis—Methotrexate—breast cancer	0.00033	0.000538	CcSEcCtD
Gentamicin—Headache—Thiotepa—breast cancer	0.000328	0.000536	CcSEcCtD
Gentamicin—LRP2—Disease—HES1—breast cancer	0.000326	0.00104	CbGpPWpGaD
Gentamicin—Arthralgia—Docetaxel—breast cancer	0.000326	0.000532	CcSEcCtD
Gentamicin—Nausea—Vinorelbine—breast cancer	0.000326	0.000532	CcSEcCtD
Gentamicin—LRP2—Disease—NCOR1—breast cancer	0.000324	0.00103	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NCOA1—breast cancer	0.000324	0.00103	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Epirubicin—breast cancer	0.000324	0.000529	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000324	0.00103	CbGpPWpGaD
Gentamicin—Stomatitis—Epirubicin—breast cancer	0.000322	0.000526	CcSEcCtD
Gentamicin—LRP2—Disease—FGF1—breast cancer	0.000321	0.00102	CbGpPWpGaD
Gentamicin—Decreased appetite—Paclitaxel—breast cancer	0.00032	0.000524	CcSEcCtD
Gentamicin—Hypertension—Capecitabine—breast cancer	0.00032	0.000523	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP19A1—breast cancer	0.000319	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—STK11—breast cancer	0.000319	0.00101	CbGpPWpGaD
Gentamicin—Hypersensitivity—Fluorouracil—breast cancer	0.000319	0.000521	CcSEcCtD
Gentamicin—LRP2—Disease—NRG1—breast cancer	0.000318	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FLT1—breast cancer	0.000317	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Disease—H2AFX—breast cancer	0.000316	0.001	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF3—breast cancer	0.000316	0.001	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SQSTM1—breast cancer	0.000316	0.001	CbGpPWpGaD
Gentamicin—Arthralgia—Capecitabine—breast cancer	0.000316	0.000516	CcSEcCtD
Gentamicin—Confusional state—Docetaxel—breast cancer	0.000315	0.000515	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000312	0.000993	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Docetaxel—breast cancer	0.000312	0.00051	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—JAG1—breast cancer	0.000312	0.000991	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000312	0.000991	CbGpPWpGaD
Gentamicin—Pruritus—Gemcitabine—breast cancer	0.000312	0.000509	CcSEcCtD
Gentamicin—Nausea—Thiotepa—breast cancer	0.000311	0.000508	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NOTCH3—breast cancer	0.00031	0.000987	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PARP1—breast cancer	0.00031	0.000987	CbGpPWpGaD
Gentamicin—Weight decreased—Doxorubicin—breast cancer	0.00031	0.000507	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—breast cancer	0.000308	0.000504	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CALCA—breast cancer	0.000307	0.000975	CbGpPWpGaD
Gentamicin—Pruritus—Fluorouracil—breast cancer	0.000306	0.0005	CcSEcCtD
Gentamicin—Thrombocytopenia—Docetaxel—breast cancer	0.000306	0.0005	CcSEcCtD
Gentamicin—Visual impairment—Methotrexate—breast cancer	0.000305	0.000499	CcSEcCtD
Gentamicin—Confusional state—Capecitabine—breast cancer	0.000305	0.000498	CcSEcCtD
Gentamicin—LRP2—Disease—ERCC2—breast cancer	0.000305	0.000969	CbGpPWpGaD
Gentamicin—Feeling abnormal—Paclitaxel—breast cancer	0.000304	0.000496	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—RPS6—breast cancer	0.000303	0.000963	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF4—breast cancer	0.000301	0.000956	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Doxorubicin—breast cancer	0.0003	0.00049	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.0003	0.000953	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCR4—breast cancer	0.0003	0.000952	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL12—breast cancer	0.0003	0.000952	CbGpPWpGaD
Gentamicin—Dizziness—Irinotecan—breast cancer	0.000299	0.000488	CcSEcCtD
Gentamicin—LRP2—Disease—ERBB3—breast cancer	0.000298	0.000947	CbGpPWpGaD
Gentamicin—Stomatitis—Doxorubicin—breast cancer	0.000298	0.000487	CcSEcCtD
Gentamicin—LRP2—Disease—FGFR2—breast cancer	0.000298	0.000946	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—COMT—breast cancer	0.000297	0.000943	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Capecitabine—breast cancer	0.000296	0.000484	CcSEcCtD
Gentamicin—Tinnitus—Methotrexate—breast cancer	0.000296	0.000483	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTP1—breast cancer	0.000295	0.000939	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Epirubicin—breast cancer	0.000295	0.000482	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PAK1—breast cancer	0.000294	0.000934	CbGpPWpGaD
Gentamicin—Urticaria—Paclitaxel—breast cancer	0.000293	0.000478	CcSEcCtD
Gentamicin—Hypotension—Docetaxel—breast cancer	0.000292	0.000477	CcSEcCtD
Gentamicin—Body temperature increased—Paclitaxel—breast cancer	0.000291	0.000476	CcSEcCtD
Gentamicin—LRP2—Metabolism—HMOX1—breast cancer	0.000291	0.000926	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ITPR1—breast cancer	0.000291	0.000924	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCC1—breast cancer	0.00029	0.000921	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TCF7L2—breast cancer	0.000289	0.000918	CbGpPWpGaD
Gentamicin—Vomiting—Irinotecan—breast cancer	0.000287	0.00047	CcSEcCtD
Gentamicin—Vomiting—Mitoxantrone—breast cancer	0.000287	0.00047	CcSEcCtD
Gentamicin—LRP2—Disease—MTHFR—breast cancer	0.000286	0.000911	CbGpPWpGaD
Gentamicin—Dizziness—Fluorouracil—breast cancer	0.000286	0.000468	CcSEcCtD
Gentamicin—Visual impairment—Epirubicin—breast cancer	0.000286	0.000467	CcSEcCtD
Gentamicin—LRP2—Disease—TERT—breast cancer	0.000286	0.000908	CbGpPWpGaD
Gentamicin—Agranulocytosis—Doxorubicin—breast cancer	0.000285	0.000466	CcSEcCtD
Gentamicin—Rash—Mitoxantrone—breast cancer	0.000285	0.000466	CcSEcCtD
Gentamicin—Rash—Irinotecan—breast cancer	0.000285	0.000466	CcSEcCtD
Gentamicin—Dermatitis—Irinotecan—breast cancer	0.000285	0.000465	CcSEcCtD
Gentamicin—Dermatitis—Mitoxantrone—breast cancer	0.000285	0.000465	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000285	0.000465	CcSEcCtD
Gentamicin—Headache—Mitoxantrone—breast cancer	0.000283	0.000463	CcSEcCtD
Gentamicin—Headache—Irinotecan—breast cancer	0.000283	0.000463	CcSEcCtD
Gentamicin—Hypotension—Capecitabine—breast cancer	0.000283	0.000462	CcSEcCtD
Gentamicin—Paraesthesia—Docetaxel—breast cancer	0.000281	0.000458	CcSEcCtD
Gentamicin—Alopecia—Methotrexate—breast cancer	0.00028	0.000458	CcSEcCtD
Gentamicin—Vomiting—Gemcitabine—breast cancer	0.00028	0.000457	CcSEcCtD
Gentamicin—LRP2—Metabolism—ABCB1—breast cancer	0.00028	0.000889	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HSP90AA1—breast cancer	0.000278	0.000885	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOTCH2—breast cancer	0.000278	0.000885	CbGpPWpGaD
Gentamicin—Rash—Gemcitabine—breast cancer	0.000278	0.000454	CcSEcCtD
Gentamicin—LRP2—Disease—FGFR1—breast cancer	0.000277	0.000882	CbGpPWpGaD
Gentamicin—Dermatitis—Gemcitabine—breast cancer	0.000277	0.000453	CcSEcCtD
Gentamicin—Tinnitus—Epirubicin—breast cancer	0.000277	0.000452	CcSEcCtD
Gentamicin—Erythema—Methotrexate—breast cancer	0.000276	0.000451	CcSEcCtD
Gentamicin—Headache—Gemcitabine—breast cancer	0.000276	0.000451	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000276	0.00045	CcSEcCtD
Gentamicin—Vomiting—Fluorouracil—breast cancer	0.000275	0.00045	CcSEcCtD
Gentamicin—LRP2—Metabolism—TYMS—breast cancer	0.000275	0.000873	CbGpPWpGaD
Gentamicin—LRP2—Disease—HIF1A—breast cancer	0.000273	0.000868	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Doxorubicin—breast cancer	0.000273	0.000446	CcSEcCtD
Gentamicin—Rash—Fluorouracil—breast cancer	0.000273	0.000446	CcSEcCtD
Gentamicin—Dermatitis—Fluorouracil—breast cancer	0.000273	0.000446	CcSEcCtD
Gentamicin—Paraesthesia—Capecitabine—breast cancer	0.000272	0.000444	CcSEcCtD
Gentamicin—Decreased appetite—Docetaxel—breast cancer	0.000272	0.000444	CcSEcCtD
Gentamicin—Hypersensitivity—Paclitaxel—breast cancer	0.000272	0.000444	CcSEcCtD
Gentamicin—LRP2—Metabolism—PLA2G4A—breast cancer	0.000271	0.000863	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTM1—breast cancer	0.000271	0.000863	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NCOR1—breast cancer	0.000271	0.000863	CbGpPWpGaD
Gentamicin—Headache—Fluorouracil—breast cancer	0.000271	0.000443	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PRL—breast cancer	0.000271	0.000861	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AGTR1—breast cancer	0.000271	0.000861	CbGpPWpGaD
Gentamicin—Nausea—Mitoxantrone—breast cancer	0.000268	0.000439	CcSEcCtD
Gentamicin—Nausea—Irinotecan—breast cancer	0.000268	0.000439	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—STK11—breast cancer	0.000267	0.000849	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ADAM10—breast cancer	0.000267	0.000849	CbGpPWpGaD
Gentamicin—Visual impairment—Doxorubicin—breast cancer	0.000265	0.000432	CcSEcCtD
Gentamicin—LRP2—Disease—CAV1—breast cancer	0.000264	0.00084	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PLG—breast cancer	0.000264	0.000839	CbGpPWpGaD
Gentamicin—Decreased appetite—Capecitabine—breast cancer	0.000263	0.00043	CcSEcCtD
Gentamicin—Alopecia—Epirubicin—breast cancer	0.000262	0.000428	CcSEcCtD
Gentamicin—Nausea—Gemcitabine—breast cancer	0.000262	0.000427	CcSEcCtD
Gentamicin—Pruritus—Paclitaxel—breast cancer	0.000261	0.000426	CcSEcCtD
Gentamicin—LRP2—Metabolism—GPX1—breast cancer	0.00026	0.000826	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF10—breast cancer	0.00026	0.000825	CbGpPWpGaD
Gentamicin—Erythema—Epirubicin—breast cancer	0.000258	0.000422	CcSEcCtD
Gentamicin—Feeling abnormal—Docetaxel—breast cancer	0.000257	0.000421	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP1A1—breast cancer	0.000257	0.000818	CbGpPWpGaD
Gentamicin—Nausea—Fluorouracil—breast cancer	0.000257	0.00042	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—breast cancer	0.000256	0.000418	CcSEcCtD
Gentamicin—LRP2—Metabolism—ERCC2—breast cancer	0.000255	0.000811	CbGpPWpGaD
Gentamicin—Anaemia—Methotrexate—breast cancer	0.000255	0.000417	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PDGFA—breast cancer	0.000251	0.000796	CbGpPWpGaD
Gentamicin—Feeling abnormal—Capecitabine—breast cancer	0.000249	0.000407	CcSEcCtD
Gentamicin—LRP2—Disease—NOS2—breast cancer	0.000249	0.00079	CbGpPWpGaD
Gentamicin—Vertigo—Methotrexate—breast cancer	0.000248	0.000405	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TGFBR2—breast cancer	0.000247	0.000785	CbGpPWpGaD
Gentamicin—Body temperature increased—Docetaxel—breast cancer	0.000247	0.000404	CcSEcCtD
Gentamicin—Leukopenia—Methotrexate—breast cancer	0.000247	0.000404	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000246	0.000783	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOTCH1—breast cancer	0.000246	0.000782	CbGpPWpGaD
Gentamicin—Dizziness—Paclitaxel—breast cancer	0.000244	0.000398	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ITPR1—breast cancer	0.000243	0.000773	CbGpPWpGaD
Gentamicin—Alopecia—Doxorubicin—breast cancer	0.000243	0.000396	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ERBB4—breast cancer	0.000241	0.000767	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP3—breast cancer	0.000241	0.000767	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT5A—breast cancer	0.000241	0.000767	CbGpPWpGaD
Gentamicin—LRP2—Disease—KIT—breast cancer	0.000241	0.000765	CbGpPWpGaD
Gentamicin—LRP2—Disease—APC—breast cancer	0.000241	0.000765	CbGpPWpGaD
Gentamicin—Urticaria—Capecitabine—breast cancer	0.00024	0.000393	CcSEcCtD
Gentamicin—LRP2—Metabolism—MTHFR—breast cancer	0.00024	0.000763	CbGpPWpGaD
Gentamicin—Body temperature increased—Capecitabine—breast cancer	0.000239	0.000391	CcSEcCtD
Gentamicin—Convulsion—Methotrexate—breast cancer	0.000239	0.000391	CcSEcCtD
Gentamicin—Erythema—Doxorubicin—breast cancer	0.000239	0.00039	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—breast cancer	0.000239	0.00039	CcSEcCtD
Gentamicin—LRP2—Disease—EGF—breast cancer	0.000238	0.000756	CbGpPWpGaD
Gentamicin—Arthralgia—Methotrexate—breast cancer	0.000235	0.000384	CcSEcCtD
Gentamicin—Vomiting—Paclitaxel—breast cancer	0.000234	0.000383	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SMAD4—breast cancer	0.000234	0.000743	CbGpPWpGaD
Gentamicin—Rash—Paclitaxel—breast cancer	0.000232	0.00038	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—IGF1R—breast cancer	0.000232	0.000739	CbGpPWpGaD
Gentamicin—Dermatitis—Paclitaxel—breast cancer	0.000232	0.000379	CcSEcCtD
Gentamicin—Vertigo—Epirubicin—breast cancer	0.000232	0.000379	CcSEcCtD
Gentamicin—Leukopenia—Epirubicin—breast cancer	0.000231	0.000378	CcSEcCtD
Gentamicin—Headache—Paclitaxel—breast cancer	0.000231	0.000377	CcSEcCtD
Gentamicin—Hypersensitivity—Docetaxel—breast cancer	0.00023	0.000376	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HES1—breast cancer	0.000228	0.000726	CbGpPWpGaD
Gentamicin—Confusional state—Methotrexate—breast cancer	0.000227	0.000371	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PLA2G4A—breast cancer	0.000227	0.000721	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NCOR1—breast cancer	0.000227	0.000721	CbGpPWpGaD
Gentamicin—LRP2—Disease—BRAF—breast cancer	0.000226	0.000719	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Methotrexate—breast cancer	0.000225	0.000368	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FGF1—breast cancer	0.000224	0.000713	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CSF2—breast cancer	0.000224	0.000713	CbGpPWpGaD
Gentamicin—Convulsion—Epirubicin—breast cancer	0.000224	0.000366	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—breast cancer	0.000223	0.000364	CcSEcCtD
Gentamicin—Hypersensitivity—Capecitabine—breast cancer	0.000223	0.000364	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NRG1—breast cancer	0.000223	0.000708	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CAV1—breast cancer	0.000221	0.000703	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—H2AFX—breast cancer	0.000221	0.000703	CbGpPWpGaD
Gentamicin—Pruritus—Docetaxel—breast cancer	0.000221	0.000361	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—breast cancer	0.000221	0.000361	CcSEcCtD
Gentamicin—Thrombocytopenia—Methotrexate—breast cancer	0.00022	0.00036	CcSEcCtD
Gentamicin—LRP2—Disease—AKT2—breast cancer	0.00022	0.0007	CbGpPWpGaD
Gentamicin—Arthralgia—Epirubicin—breast cancer	0.00022	0.000359	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—E2F1—breast cancer	0.00022	0.000698	CbGpPWpGaD
Gentamicin—Nausea—Paclitaxel—breast cancer	0.000219	0.000358	CcSEcCtD
Gentamicin—Vertigo—Doxorubicin—breast cancer	0.000215	0.000351	CcSEcCtD
Gentamicin—Pruritus—Capecitabine—breast cancer	0.000214	0.00035	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—breast cancer	0.000214	0.000349	CcSEcCtD
Gentamicin—Confusional state—Epirubicin—breast cancer	0.000213	0.000347	CcSEcCtD
Gentamicin—LRP2—Disease—PIK3CD—breast cancer	0.000212	0.000673	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.000211	0.000672	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SPP1—breast cancer	0.000211	0.000671	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Epirubicin—breast cancer	0.000211	0.000344	CcSEcCtD
Gentamicin—Hypotension—Methotrexate—breast cancer	0.00021	0.000344	CcSEcCtD
Gentamicin—LRP2—Disease—SERPINE1—breast cancer	0.000209	0.000665	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB3—breast cancer	0.000209	0.000663	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGFR2—breast cancer	0.000208	0.000662	CbGpPWpGaD
Gentamicin—Convulsion—Doxorubicin—breast cancer	0.000207	0.000338	CcSEcCtD
Gentamicin—Dizziness—Docetaxel—breast cancer	0.000207	0.000338	CcSEcCtD
Gentamicin—Thrombocytopenia—Epirubicin—breast cancer	0.000206	0.000337	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—breast cancer	0.000206	0.000337	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000205	0.000335	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000205	0.000652	CbGpPWpGaD
Gentamicin—Arthralgia—Doxorubicin—breast cancer	0.000203	0.000332	CcSEcCtD
Gentamicin—Paraesthesia—Methotrexate—breast cancer	0.000202	0.00033	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CG—breast cancer	0.000202	0.000641	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000201	0.000638	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—breast cancer	0.0002	0.000636	CbGpPWpGaD
Gentamicin—Dizziness—Capecitabine—breast cancer	0.0002	0.000327	CcSEcCtD
Gentamicin—LRP2—Disease—NOS3—breast cancer	0.0002	0.000635	CbGpPWpGaD
Gentamicin—Vomiting—Docetaxel—breast cancer	0.000199	0.000325	CcSEcCtD
Gentamicin—Rash—Docetaxel—breast cancer	0.000197	0.000322	CcSEcCtD
Gentamicin—Hypotension—Epirubicin—breast cancer	0.000197	0.000322	CcSEcCtD
Gentamicin—Dermatitis—Docetaxel—breast cancer	0.000197	0.000322	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—breast cancer	0.000197	0.000321	CcSEcCtD
Gentamicin—Decreased appetite—Methotrexate—breast cancer	0.000196	0.00032	CcSEcCtD
Gentamicin—Headache—Docetaxel—breast cancer	0.000196	0.00032	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—breast cancer	0.000195	0.000319	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FGFR1—breast cancer	0.000194	0.000617	CbGpPWpGaD
Gentamicin—Vomiting—Capecitabine—breast cancer	0.000192	0.000314	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000192	0.000314	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HIF1A—breast cancer	0.000191	0.000608	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Doxorubicin—breast cancer	0.000191	0.000312	CcSEcCtD
Gentamicin—Rash—Capecitabine—breast cancer	0.000191	0.000312	CcSEcCtD
Gentamicin—Dermatitis—Capecitabine—breast cancer	0.000191	0.000311	CcSEcCtD
Gentamicin—LRP2—Disease—MDM2—breast cancer	0.00019	0.000603	CbGpPWpGaD
Gentamicin—Headache—Capecitabine—breast cancer	0.00019	0.00031	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—breast cancer	0.000189	0.000309	CcSEcCtD
Gentamicin—LRP2—Disease—RAF1—breast cancer	0.000189	0.0006	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB2—breast cancer	0.000187	0.000594	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LEP—breast cancer	0.000187	0.000594	CbGpPWpGaD
Gentamicin—Nausea—Docetaxel—breast cancer	0.000186	0.000303	CcSEcCtD
Gentamicin—Feeling abnormal—Methotrexate—breast cancer	0.000186	0.000303	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CAV1—breast cancer	0.000185	0.000588	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTOR—breast cancer	0.000184	0.000586	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CB—breast cancer	0.000184	0.000586	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD4—breast cancer	0.000184	0.000585	CbGpPWpGaD
Gentamicin—Decreased appetite—Epirubicin—breast cancer	0.000183	0.000299	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—KDR—breast cancer	0.000183	0.000582	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—breast cancer	0.000183	0.000581	CbGpPWpGaD
Gentamicin—Hypotension—Doxorubicin—breast cancer	0.000182	0.000298	CcSEcCtD
Gentamicin—Nausea—Capecitabine—breast cancer	0.00018	0.000294	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TFRC—breast cancer	0.000179	0.000569	CbGpPWpGaD
Gentamicin—Urticaria—Methotrexate—breast cancer	0.000179	0.000292	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ESR1—breast cancer	0.000178	0.000567	CbGpPWpGaD
Gentamicin—Body temperature increased—Methotrexate—breast cancer	0.000178	0.000291	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000178	0.00029	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CD—breast cancer	0.000177	0.000563	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FN1—breast cancer	0.000176	0.00056	CbGpPWpGaD
Gentamicin—Paraesthesia—Doxorubicin—breast cancer	0.000175	0.000286	CcSEcCtD
Gentamicin—LRP2—Metabolism—ALB—breast cancer	0.000175	0.000556	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NFKBIA—breast cancer	0.000174	0.000553	CbGpPWpGaD
Gentamicin—Feeling abnormal—Epirubicin—breast cancer	0.000174	0.000284	CcSEcCtD
Gentamicin—LRP2—Disease—CDKN1B—breast cancer	0.000173	0.00055	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOTCH1—breast cancer	0.000172	0.000548	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000172	0.000548	CbGpPWpGaD
Gentamicin—Decreased appetite—Doxorubicin—breast cancer	0.00017	0.000277	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—KIT—breast cancer	0.000169	0.000536	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APC—breast cancer	0.000169	0.000536	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—breast cancer	0.000169	0.000536	CbGpPWpGaD
Gentamicin—Urticaria—Epirubicin—breast cancer	0.000167	0.000274	CcSEcCtD
Gentamicin—LRP2—Metabolism—NOS3—breast cancer	0.000167	0.000532	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGF—breast cancer	0.000167	0.00053	CbGpPWpGaD
Gentamicin—Body temperature increased—Epirubicin—breast cancer	0.000167	0.000272	CcSEcCtD
Gentamicin—Hypersensitivity—Methotrexate—breast cancer	0.000166	0.000271	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000164	0.000523	CbGpPWpGaD
Gentamicin—LRP2—Disease—CTNNB1—breast cancer	0.000164	0.00052	CbGpPWpGaD
Gentamicin—Feeling abnormal—Doxorubicin—breast cancer	0.000161	0.000263	CcSEcCtD
Gentamicin—LRP2—Disease—CDKN1A—breast cancer	0.00016	0.000508	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTEN—breast cancer	0.000159	0.000507	CbGpPWpGaD
Gentamicin—Pruritus—Methotrexate—breast cancer	0.000159	0.00026	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000159	0.000505	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—BRAF—breast cancer	0.000158	0.000504	CbGpPWpGaD
Gentamicin—Hypersensitivity—Epirubicin—breast cancer	0.000155	0.000254	CcSEcCtD
Gentamicin—Urticaria—Doxorubicin—breast cancer	0.000155	0.000253	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CB—breast cancer	0.000154	0.000491	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF1—breast cancer	0.000154	0.000491	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	0.000154	0.000491	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT2—breast cancer	0.000154	0.00049	CbGpPWpGaD
Gentamicin—Body temperature increased—Doxorubicin—breast cancer	0.000154	0.000252	CcSEcCtD
Gentamicin—LRP2—Metabolism—PTGS2—breast cancer	0.000153	0.000486	CbGpPWpGaD
Gentamicin—Pruritus—Epirubicin—breast cancer	0.000149	0.000244	CcSEcCtD
Gentamicin—Dizziness—Methotrexate—breast cancer	0.000149	0.000243	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PIK3CD—breast cancer	0.000148	0.000471	CbGpPWpGaD
Gentamicin—LRP2—Disease—SRC—breast cancer	0.000148	0.00047	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SERPINE1—breast cancer	0.000147	0.000466	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000145	0.000462	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—breast cancer	0.000144	0.000235	CcSEcCtD
Gentamicin—Vomiting—Methotrexate—breast cancer	0.000143	0.000234	CcSEcCtD
Gentamicin—LRP2—Disease—STAT3—breast cancer	0.000143	0.000453	CbGpPWpGaD
Gentamicin—Rash—Methotrexate—breast cancer	0.000142	0.000232	CcSEcCtD
Gentamicin—Dermatitis—Methotrexate—breast cancer	0.000142	0.000232	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	0.000142	0.00045	CbGpPWpGaD
Gentamicin—Headache—Methotrexate—breast cancer	0.000141	0.00023	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NOS3—breast cancer	0.00014	0.000445	CbGpPWpGaD
Gentamicin—Dizziness—Epirubicin—breast cancer	0.000139	0.000228	CcSEcCtD
Gentamicin—Pruritus—Doxorubicin—breast cancer	0.000138	0.000225	CcSEcCtD
Gentamicin—LRP2—Disease—MAPK3—breast cancer	0.000136	0.000433	CbGpPWpGaD
Gentamicin—Vomiting—Epirubicin—breast cancer	0.000134	0.000219	CcSEcCtD
Gentamicin—Nausea—Methotrexate—breast cancer	0.000134	0.000219	CcSEcCtD
Gentamicin—LRP2—Metabolism—PTEN—breast cancer	0.000133	0.000424	CbGpPWpGaD
Gentamicin—Rash—Epirubicin—breast cancer	0.000133	0.000217	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—breast cancer	0.000133	0.000217	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MDM2—breast cancer	0.000133	0.000422	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—breast cancer	0.000132	0.000421	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RAF1—breast cancer	0.000132	0.00042	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFB1—breast cancer	0.000132	0.00042	CbGpPWpGaD
Gentamicin—Headache—Epirubicin—breast cancer	0.000132	0.000216	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—RELA—breast cancer	0.000132	0.000419	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—breast cancer	0.000131	0.000416	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000131	0.000415	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGFR—breast cancer	0.00013	0.000412	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CB—breast cancer	0.000129	0.00041	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MTOR—breast cancer	0.000129	0.00041	CbGpPWpGaD
Gentamicin—Dizziness—Doxorubicin—breast cancer	0.000129	0.000211	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000125	0.000398	CbGpPWpGaD
Gentamicin—Nausea—Epirubicin—breast cancer	0.000125	0.000205	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CXCL8—breast cancer	0.000124	0.000394	CbGpPWpGaD
Gentamicin—Vomiting—Doxorubicin—breast cancer	0.000124	0.000203	CcSEcCtD
Gentamicin—Rash—Doxorubicin—breast cancer	0.000123	0.000201	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—breast cancer	0.000123	0.000201	CcSEcCtD
Gentamicin—LRP2—Disease—KRAS—breast cancer	0.000122	0.000389	CbGpPWpGaD
Gentamicin—Headache—Doxorubicin—breast cancer	0.000122	0.0002	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CDKN1B—breast cancer	0.000121	0.000385	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—breast cancer	0.000119	0.000378	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—breast cancer	0.000119	0.000377	CbGpPWpGaD
Gentamicin—Nausea—Doxorubicin—breast cancer	0.000116	0.000189	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCND1—breast cancer	0.000116	0.000368	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JUN—breast cancer	0.000115	0.000367	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CTNNB1—breast cancer	0.000115	0.000364	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—breast cancer	0.000112	0.000357	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—breast cancer	0.000112	0.000357	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1A—breast cancer	0.000112	0.000356	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—breast cancer	0.000112	0.000355	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK8—breast cancer	0.000109	0.000347	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—breast cancer	0.000104	0.000331	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SRC—breast cancer	0.000103	0.000329	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—breast cancer	0.000101	0.00032	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—breast cancer	9.98e-05	0.000317	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—breast cancer	9.96e-05	0.000316	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK3—breast cancer	9.54e-05	0.000303	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—breast cancer	9.42e-05	0.000299	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—breast cancer	9.27e-05	0.000295	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFB1—breast cancer	9.25e-05	0.000294	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—breast cancer	9.18e-05	0.000292	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—breast cancer	9.07e-05	0.000288	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—breast cancer	8.57e-05	0.000272	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—breast cancer	7.87e-05	0.00025	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	7.84e-05	0.000249	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—breast cancer	7.69e-05	0.000244	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—breast cancer	7.62e-05	0.000242	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—breast cancer	7.28e-05	0.000232	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	7.09e-05	0.000225	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—breast cancer	6.97e-05	0.000222	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—breast cancer	6.43e-05	0.000204	CbGpPWpGaD
